Boston Trust Walden Corp Prestige Consumer Healthcare Inc. Transaction History
Boston Trust Walden Corp
- $13.4 Billion
- Q3 2025
A detailed history of Boston Trust Walden Corp transactions in Prestige Consumer Healthcare Inc. stock. As of the latest transaction made, Boston Trust Walden Corp holds 786,086 shares of PBH stock, worth $47.2 Million. This represents 0.37% of its overall portfolio holdings.
Number of Shares
786,086
Previous 800,166
1.76%
Holding current value
$47.2 Million
Previous $63.9 Million
23.23%
% of portfolio
0.37%
Previous 0.46%
Shares
5 transactions
Others Institutions Holding PBH
# of Institutions
387Shares Held
52.5MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY8.28MShares$497 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.49MShares$330 Million0.01% of portfolio
-
Ariel Investments, LLC Chicago, IL3.59MShares$216 Million2.75% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.59MShares$156 Million0.04% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA2.21MShares$133 Million0.35% of portfolio
About Prestige Consumer Healthcare Inc.
- Ticker PBH
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,762,600
- Market Cap $2.99B
- Description
- Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's an...